Skip to main content
ImmuneCited

Descrizione

Clinical trial data on resveratrol supplementation in MASLD patients are summarized, showing variable effects on liver enzymes, steatosis, and metabolic parameters.

Figure 5

Source Paper

Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?

International journal of molecular sciences (2024)

PMID: 38612556

DOI: 10.3390/ijms25073746

Cite This Figure

![Figure 5: Clinical trial data on resveratrol supplementation in MASLD patients are summarized, showing variable effects on liver enzymes, steatosis, and metabolic parameters.]()

> Source: Kamila Kasprzak-Drozd et al. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Diseas." *International journal of molecular sciences*, 2024. PMID: [38612556](https://pubmed.ncbi.nlm.nih.gov/38612556/)
<figure>
  <img src="" alt="Clinical trial data on resveratrol supplementation in MASLD patients are summarized, showing variable effects on liver enzymes, steatosis, and metabolic parameters." />
  <figcaption>Figure 5. Clinical trial data on resveratrol supplementation in MASLD patients are summarized, showing variable effects on liver enzymes, steatosis, and metabolic parameters.<br>  Source: Kamila Kasprzak-Drozd et al. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Diseas." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38612556/">38612556</a></figcaption>
</figure>